{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:16Z","timestamp":1786980256427,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00467-021-05092-x","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T19:05:17Z","timestamp":1620846317000},"page":"947-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4087-9561","authenticated-orcid":false,"given":"Ron","family":"Hogg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"5092_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/bmj.3.5984.611","volume":"3","author":"JGP Sissons","year":"1975","unstructured":"Sissons JGP, Woodrow DF, Curtis JR, Evans DJ, Gower PE, Sloper JC (1975) Isolated glomerulonephritis with mesangial IgA deposits. Br Med J 3:611\u2013614","journal-title":"Br Med J"},{"key":"5092_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ki.1983.32","volume":"23","author":"WM Bennett","year":"1983","unstructured":"Bennett WM, Kincaid-Smith P (1983) Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and kidney dysfunction. Kidney Int 23:393\u2013400","journal-title":"Kidney Int"},{"key":"5092_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ki.1986.33","volume":"29","author":"JR Beukhof","year":"1986","unstructured":"Beukhof JR, Kardaun O, Schaafsma W, Poortema K, Donker AJM, Hoedemaeker PJ, Van der Hem GK (1986) Toward individual prognosis of IgA nephropathy. Kidney Int 29:549\u2013556","journal-title":"Kidney Int"},{"key":"5092_CR4","first-page":"363","volume":"59","author":"G D\u2019Amico","year":"1986","unstructured":"D\u2019Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano Di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, Duca G (1986) Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 59:363\u2013378","journal-title":"Q J Med"},{"key":"5092_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.semnephrol.2004.01.001","volume":"24","author":"D\u2019Amico","year":"2004","unstructured":"D\u2019Amico (2004) Natural history of Idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24:179\u2013196","journal-title":"Semin Nephrol"},{"key":"5092_CR6","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1093\/ndt\/gfp273","volume":"24","author":"M Goto","year":"2009","unstructured":"Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y (2009) A scoring system to predict kidney outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant 24:3068\u20133074","journal-title":"Nephrol Dial Transplant"},{"key":"5092_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000364954","volume":"40","author":"W Le","year":"2014","unstructured":"Le W, Liang S, Chen H, Wang S, Zhang W, Wang X, Wang J, Zeng C-H, Liu Z-H (2014) Long-term outcome of IgA nephropathy patients with recurrent macroscopic hematuria. Am J Nephrol 40:43\u201350","journal-title":"Am J Nephrol"},{"key":"5092_CR8","first-page":"217","volume":"28","author":"N Yoshikawa","year":"1987","unstructured":"Yoshikawa N, Ito H, Iijima K, Nakahara C, Maehara K, Hasegawa O, Okada S, Matsuo T (1987) Macroscopic hematuria in childhood IgA nephropathy. Clin Nephrol 28:217\u2013221","journal-title":"Clin Nephrol"},{"key":"5092_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF01453658","volume":"5","author":"T Linn\u00e9","year":"1991","unstructured":"Linn\u00e9 T, Berg U, Bohman S-O, Sigstr\u00f6m L (1991) Course and long-term outcome of idiopathic IgA nephropathy in children. Pediatr Nephrol 5:383\u2013386","journal-title":"Pediatr Nephrol"},{"key":"5092_CR10","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3390\/jcm9072058","volume":"9","author":"J-S Suh","year":"2020","unstructured":"Suh J-S, Jang KM, Hyun H, Cho MH, Lee JH, Park YS et al (2020) Remission of proteinuria may protect against progression to chronic kidney disease in pediatric-onset IgA nephropathy. J Clin Med 9:2058","journal-title":"J Clin Med"},{"key":"5092_CR11","first-page":"206","volume":"19","author":"P Kincaid-Smith","year":"1983","unstructured":"Kincaid-Smith P, Bennett WM, Dowling JP, Ryan GB (1983) Acute kidney failure and tubular necrosis associated with hematuria due to glomerulonephritis. Clin Nephrol 19:206\u2013210","journal-title":"Clin Nephrol"},{"key":"5092_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ki.1985.120","volume":"28","author":"M Praga","year":"1985","unstructured":"Praga M, Gutierrez-Millet V, Navas JJ, Ruilope LM, Morales JM, Alcazar JM, Bello I, Rodicio JL (1985) Acute worsening of kidney function during episodes of macroscopic hematuria in IgA nephropathy. Kidney Int 28:69\u201374","journal-title":"Kidney Int"},{"key":"5092_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1055\/s-2007-1025414","volume":"203","author":"B Lettgen","year":"1991","unstructured":"Lettgen B, Rascher W (1991) Acute reversible renal failure in IgA nephritis. Klin Padiatr 203:124\u2013128","journal-title":"Klin Padiatr"},{"key":"5092_CR14","first-page":"195","volume":"8","author":"C Delclaux","year":"1993","unstructured":"Delclaux C, Jacquot C, Callard P, Kleinknecht (1993) Acute reversible kidney failure with macroscopic haematuria in IgA nephropathy. Nephrol Dial Transplant 8:195\u2013199","journal-title":"Nephrol Dial Transplant"},{"key":"5092_CR15","first-page":"624","volume":"10","author":"GB Fogazzi","year":"1995","unstructured":"Fogazzi GB, Imbasciati E, Moroni G, Scalia A, Mihatsch MJ, Ponticelli C (1995) Reversible acute kidney failure from gross haematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction. Nephrol Dial Transplant 10:624\u2013629","journal-title":"Nephrol Dial Transplant"},{"key":"5092_CR16","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ki.1989.292","volume":"36","author":"PA Hill","year":"1989","unstructured":"Hill PA, Davies DJ, Kincaid-Smith P, Ryan GB (1989) Ultrastructural changes in renal tubules associated with glomerular bleeding. Kidney Int 36:992\u2013997","journal-title":"Kidney Int"},{"key":"5092_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000409747","volume":"40","author":"P Kincaid-Smith","year":"1984","unstructured":"Kincaid-Smith P, Ryan GB, Dowling JP, Nicholls K (1984) Acute renal failure in mesangial IgA nephropathy. Contrib Nephrol 40:182\u2013186","journal-title":"Contrib Nephrol"},{"key":"5092_CR18","first-page":"349","volume":"42","author":"DK Packham","year":"1994","unstructured":"Packham DK, Hewitson TD, Yan HD, Elliott CE, Nicholls K, Becker GJ (1994) Acute kidney failure in IgA nephropathy. Clin Nephrol 42:349\u2013353","journal-title":"Clin Nephrol"},{"key":"5092_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1744-9987.2009.00723.x","volume":"13","author":"R Kveder","year":"2009","unstructured":"Kveder R, Lindic J, Ales A, Kovasc D, Vizjak A, Ferluga D (2009) Acute kidney injury in immunoglobulin A nephropathy: potential role of macroscopic hematuria and acute tubulointerstitial injury. Ther Apher Dial 13:273\u2013277","journal-title":"Ther Apher Dial"},{"key":"5092_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/ckj\/sft004","volume":"6","author":"R Topaloglu","year":"2013","unstructured":"Topaloglu R, Orhan D, Bilginer Y, Karabulut E, Ozaltin F, Duzova A, Kale G, Besbas N (2013) Clinicopathological and immunohistological features in childhood IgA nephropathy: a single center experience. Clin Kidney J 6:169\u2013175","journal-title":"Clin Kidney J"},{"key":"5092_CR21","first-page":"610","volume":"54","author":"MG Chen","year":"2016","unstructured":"Chen MG, Ye XH, Liang HY, Yang Q (2016) Clinical and pathological analysis of IgA nephropathy with acute kidney injury. Zhonghua Er Ke Za Zhi 54:610\u2013613 (Article in Chinese)","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"5092_CR22","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ekir.2018.03.013","volume":"3","author":"A Cambier","year":"2018","unstructured":"Cambier A, Rabant M, Peuchmaur M, Hertig A, Deschenes G, Couchoud C, Kolko A, Salomon R, Hogan J, Robert T (2018) Immunosuppressive treatment in children with IgA nephropathy and the clinical value of podocytopathic features. Kidney Int Reports 3:916\u2013925","journal-title":"Kidney Int Reports"},{"key":"5092_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2215\/CJN.02670706","volume":"2","author":"E Guti\u00e9rrez","year":"2007","unstructured":"Guti\u00e9rrez E, Gonz\u00e1lez E, Hern\u00e1ndez E, Morales E, Angel Martinez M, Usera G, Praga M (2007) Factors that determine an incomplete recovery of kidney function in macrohematuria-induced acute kidney failure of IgA nephropathy. Clin J Am Soc Nephrol 2:51\u201357","journal-title":"Clin J Am Soc Nephrol"},{"key":"5092_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2215\/CJN.01970211","volume":"7","author":"JA Moreno","year":"2012","unstructured":"Moreno JA, Mart\u00edn-Cleary C, Guti\u00e9rrez E, Toldos O, Blanco-Colio LM, Praga M, Ortiz A, Egido J (2012) AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin J Am Soc Nephrol 7:175\u2013184","journal-title":"Clin J Am Soc Nephrol"},{"key":"5092_CR25","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40620-020-00725-0","volume":"33","author":"R Coppo","year":"2020","unstructured":"Coppo R, Robert T (2020) IgA nephropathy in children and in adults: two separate entities or the same disease? J Nephrol 33:1219\u20131229","journal-title":"J Nephrol"},{"key":"5092_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/08860221003646345","volume":"32","author":"YK Wen","year":"2010","unstructured":"Wen YK, Chen ML (2010) The spectrum of acute kidney failure in IgA nephropathy. Ren Fail 32:428\u2013433","journal-title":"Ren Fail"},{"key":"5092_CR27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/nep.13592","volume":"24","author":"SC Yeo","year":"2019","unstructured":"Yeo SC, Goh SM, Barratt J (2019) Is immunoglobulin A nephropathy different in different ethnic populations? Nephrology 24:885\u2013895","journal-title":"Nephrology"},{"key":"5092_CR28","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/ndt\/14.6.1391","volume":"14","author":"NS Sheerin","year":"1999","unstructured":"Sheerin NS, Sacks SH, Fogazzi GB (1999) In vitro eryrythrophagocytosis by kidney tubular cells and tubular toxicity by haemoglobin and iron. Nephrol Dial Transplant 14:1391\u20131397","journal-title":"Nephrol Dial Transplant"},{"key":"5092_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5527\/wjn.v4.i2.185","volume":"4","author":"C Yuste","year":"2015","unstructured":"Yuste C, Gutierrez E, Sevillano AN, Rubio-Navarro A, Amaro-Villalobos JM, Ortiz A, Egido J, Praga M, Moreno JA (2015) Pathogenesis of glomerular haematuria. World J Nephrol 4:185\u2013195","journal-title":"World J Nephrol"},{"key":"5092_CR30","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3390\/ijms20092205","volume":"20","author":"JA Moreno","year":"2019","unstructured":"Moreno JA, Sevillano A, Guti\u00e9rrez E, Guerrero-Hue M, V\u00e1zquez-Carballo C, Yuste C, Herencia C, Garcia-Caballero C, Praga M, Egido J (2019) Glomerular Hematuria: cause or consequence of renal inflammation? Int J Mol Sci 20:2205","journal-title":"Int J Mol Sci"},{"key":"5092_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/path.5011","volume":"244","author":"A Rubio-Navarro","year":"2018","unstructured":"Rubio-Navarro A, Sanchez-Nino MD, Guerrero-Hue M, Garcia-Caballero C, Gutierrez E, Yuste C, Sevillano A, Praga M, Egea J, Roman E, Cannata P, Ortega R, Cortegano I, de Andres B, Gaspar ML, Cadenas S, Ortiz A, Egido J, Moreno JA (2018) Podocytes are new cellular targets of haemoglobin-mediated renal damage. J Pathol 244:296\u2013310","journal-title":"J Pathol"},{"key":"5092_CR32","doi-asserted-by":"publisher","unstructured":"Van Swelm RPL, Wetzels JFM, Swinkels DW (2020) The multifaceted role of iron in health and renal disease. Nat Rev Nephrol. https:\/\/doi.org\/10.1038\/s41581-019-019-5","DOI":"10.1038\/s41581-019-019-5"},{"key":"5092_CR33","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1053\/j.ajkd.2009.04.024","volume":"54","author":"SV Brodsky","year":"2009","unstructured":"Brodsky SV, Satoskar A, Chen J, Nadasdy G, Eagen JW, Hamirani M, Hebert L, Calomeni E, Nadasdy T (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54:1121\u20131126","journal-title":"Am J Kidney Dis"},{"key":"5092_CR34","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2215\/CJN.02470319","volume":"14","author":"RJ Glassock","year":"2019","unstructured":"Glassock RJ (2019) Anticoagulant-related nephropathy. It\u2019s the Real McCoy. Clin J Am Soc Nephrol 14:935\u2013937","journal-title":"Clin J Am Soc Nephrol"},{"key":"5092_CR35","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1093\/ndt\/gfl342","volume":"21","author":"K Wakai","year":"2006","unstructured":"Wakai K, Kawamura T, Endoh M, Kojima M, Tomino Y, Tamakoshi A, Ohno Y, Inaba Y, Sakai H (2006) A scoring system to predict kidney outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant 21:2800\u20132808","journal-title":"Nephrol Dial Transplant"},{"key":"5092_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00467-015-3119-1","volume":"31","author":"JA Moreno","year":"2016","unstructured":"Moreno JA, Yuste C, Gutierrez E, Sevillano AM, Rubin-Navarro A, Amaro-Villalobos JM, Praga M, Egido J (2016) Hematuria as a risk factor for chronic kidney disease progression in glomerular diseases. A review. Pediatr Nephrol 31:523\u2013533","journal-title":"Pediatr Nephrol"},{"key":"5092_CR37","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1681\/ASN.2017060639","volume":"28","author":"R Coppo","year":"2017","unstructured":"Coppo R, Fervenza FC (2017) Persistent microscopic hematuria as a risk factor for progression of IgA nephropathy: new floodlight on a nearly forgotten biomarker. J Am Soc Nephrol 28:2831\u20132834","journal-title":"J Am Soc Nephrol"},{"key":"5092_CR38","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","volume":"27","author":"W Le","year":"2012","unstructured":"Le W, Liang SS, Hu YL, Deng KP, Bao H, Zeng CH, Liu ZH (2012) Long-term kidney survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant 27:1479\u20131485","journal-title":"Nephrol Dial Transplant"},{"key":"5092_CR39","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1681\/ASN.2017010108","volume":"28","author":"AM Sevillano","year":"2017","unstructured":"Sevillano AM, Guti\u00e9rrez E, Yuste C, Cavero T, M\u00e9rida A, Rodr\u00edruez P, Garcia A, Morales E, Fern\u00e1ndez C, Mart\u00ednez MA, Moreno JA, Praga M (2017) Remission of hematuria improves survival in IgA nephropathy. J Am Soc Nephrol 28:3089\u20133099","journal-title":"J Am Soc Nephrol"},{"key":"5092_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.ajkd.2019.11.008","volume":"26","author":"GZ Yu","year":"2020","unstructured":"Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, Sui GL, Zhou XJ, Xing Y, Li HX, Lv JC, Zhang H (2020) Persistent hematuria and kidney disease progression in IgA nephropathy: a cohort study. Am J Kidney Dis 26:90\u201399","journal-title":"Am J Kidney Dis"},{"key":"5092_CR41","first-page":"41","volume":"33","author":"M Miura","year":"1990","unstructured":"Miura M, Nomoto Y, Sakai H (1990) Evidence of enhanced uric acid clearance in macrohematuric patients with IgA nephropathy: prognostic significance of macrohematuria. Clin Nephrol 33:41\u201346","journal-title":"Clin Nephrol"},{"key":"5092_CR42","first-page":"327","volume":"71","author":"Z Konopielko","year":"1996","unstructured":"Konopielko Z, Zawadzki J, Wyszynska T (1996) Uric acid metabolism abnormalities in IgA nephropathies. Pediatr Pol 71:327\u2013330","journal-title":"Pediatr Pol"},{"key":"5092_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1046\/j.1523-1755.1998.00065.x","volume":"54","author":"M Praga","year":"1998","unstructured":"Praga M, Martinez MA, Andres A, Alegre R, Vara J, Morales E, Herrero JC, Novo O, Rodicio JL (1998) Association of thin basement nephropathy with hypercalciuria, hyperuricosuria and nephrolithiasis. Kidney Int 54:915\u2013920","journal-title":"Kidney Int"},{"key":"5092_CR44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/08998280.2020.1860428","volume":"34","author":"KL Birkemeier","year":"2021","unstructured":"Birkemeier KL, Hogg RJ, Patel DB, Acosta AA, Waxman JE (2021) Hyperuricosuria, hematuria, and novel bladder images with IgA nephropathy. Proc (Baylor Univ Med Cent) 34:294\u2013296","journal-title":"Proc (Baylor Univ Med Cent)"},{"key":"5092_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ki.1989.166","volume":"36","author":"A Andres","year":"1989","unstructured":"Andres A, Praga M, Bello I, Diaz-Rolon JA, Gutierrez-Millet V, Morales JM, Rodicio JL (1989) Hematuria due to hypercalciuria and hyperuricosuria in adult patients. Kidney Int 36:96\u201399","journal-title":"Kidney Int"},{"key":"5092_CR46","first-page":"878","volume":"143","author":"M Sanchez Bayle","year":"1989","unstructured":"Sanchez Bayle M, Ramo Mancheno C (1989) Hyperuricosuria and microhematuria in childhood. Am J Dis Child 143:878\u2013879","journal-title":"Am J Dis Child"},{"key":"5092_CR47","first-page":"288","volume":"48","author":"HC Perrone","year":"1997","unstructured":"Perrone HC, Stapleton FB, Toprovski J, Schor N (1997) Hematuria due to hyperuricosuria in children: 36-month follow-up. Clin Nephrol 48:288\u2013291","journal-title":"Clin Nephrol"},{"key":"5092_CR48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1542\/peds.107.1.86","volume":"107","author":"A La Manna","year":"2001","unstructured":"La Manna A, Polito C, Marte A, Lovene A, Di Toro R (2001) Hyperuricosuria in children: clinical presentation and natural history. Pediatrics 107:86\u201390","journal-title":"Pediatrics"},{"key":"5092_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038904","volume":"7","author":"J Xie","year":"2012","unstructured":"Xie J, Kiryluk K, Wang W, Wang Z, Guo S, Shen P, Ren H, Pan X, Chen X, Zhang W, Li X, Shi H, Li Y, Gharavi AG, Chen N (2012) Predicting progression of IgA nephropathy: new clinical progression risk score. PLoS One 7:e38904","journal-title":"PLoS One"},{"key":"5092_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000331453","volume":"35","author":"Y Shi","year":"2012","unstructured":"Shi Y, Chen W, Jalal D, Li Z, Chen W, Mao H, Yang Q, Johnson RJ, Yu X (2012) Clinical outcome of hyperuricemia in IgA Nephropathy: a retrospective cohort study and randomized controlled trial. Kidney Blood Press Res 35:153\u2013160","journal-title":"Kidney Blood Press Res"},{"key":"5092_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5414\/CN107813","volume":"80","author":"GY Cheng","year":"2013","unstructured":"Cheng GY, Liu DW, Zhang N, Tang L, Zhao ZZ, Liu ZS (2013) Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow up. Clin Nephrol 80:40\u201346","journal-title":"Clin Nephrol"},{"key":"5092_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000489962","volume":"48","author":"B Zhu","year":"2018","unstructured":"Zhu B, Yu D, Lv J, Lin Y, Li Q, Yin J, Du Y et al (2018) Uric acid as a predictor of immunoglobulin A nephropathy progression: a cohort study of 1965 cases. Am J Nephrol 48:127\u2013136","journal-title":"Am J Nephrol"},{"key":"5092_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ndt\/15.1.34","volume":"15","author":"J Syrj\u00e4nen","year":"2000","unstructured":"Syrj\u00e4nen J, Mustonen J, Pasternack A (2000) Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 15:34\u201342","journal-title":"Nephrol Dial Transplant"},{"key":"5092_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/ckj\/sfs131","volume":"6","author":"T Kov\u00e1cs","year":"2013","unstructured":"Kov\u00e1cs T, Vas T, Kovesdy CP, K\u00e9s\u00f5li I, S\u00e1gi B, Wittmann I, Nagy J (2013) Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy. Clin Kidney J 6:395\u2013401","journal-title":"Clin Kidney J"},{"key":"5092_CR55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000045939","volume":"87","author":"I Ohno","year":"2001","unstructured":"Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M (2001) Serum uric acid and kidney prognosis in patients with IgA nephropathy. Nephron 87:333\u2013339","journal-title":"Nephron"},{"key":"5092_CR56","doi-asserted-by":"publisher","first-page":"e9175","DOI":"10.1371\/journal.pone.0091756","volume":"9","author":"T Moriyama","year":"2014","unstructured":"Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, Itabashi M, Takei T, Uchida K, Nitta K (2014) Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One 9:e9175","journal-title":"PLoS One"},{"key":"5092_CR57","doi-asserted-by":"publisher","first-page":"e0160828","DOI":"10.1371\/journal.pone.0160828","volume":"11","author":"Y Nagasawa","year":"2016","unstructured":"Nagasawa Y, Yamamoto R, Shoji T, Shinzawa M, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y, Nakanishi T (2016) Serum uric acid level predicts progression of IgA nephropathy in females but not in males. PLoS One 11:e0160828","journal-title":"PLoS One"},{"key":"5092_CR58","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/hr.2016.134","volume":"40","author":"Y Matsukuma","year":"2017","unstructured":"Matsukuma Y, Masutani K, Tanaka S, Tsuchimoto A, Fujisaki K, Torisu K, Katafuchi R, Hirakata H, Tsuruya K, Kitazono T (2017) A J-shaped association between serum uric acid levels and poor kidney survival in female patients with IgA nephropathy. Hypertens Res 40:291\u2013297","journal-title":"Hypertens Res"},{"key":"5092_CR59","first-page":"174","volume":"26","author":"HJ Chin","year":"2007","unstructured":"Chin HJ, Na KY, Cheong H, Kim YS, Kim S, Chae DW (2007) The impact of serum uric acid level on the progression of IgA nephropathy. Korean J Nephrol 26:174\u2013181","journal-title":"Korean J Nephrol"},{"key":"5092_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.krcp.2012.07.003","volume":"31","author":"S-J Kim","year":"2012","unstructured":"Kim S-J, Kim J-H, Gil H-W, Yang J-O, Lee E-Y, Hong S-Y (2012) Hyperuricemia as a marker for progression of immunoglobulin A nephropathy. Kidney Res Clin Pract 31:186\u2013191","journal-title":"Kidney Res Clin Pract"},{"key":"5092_CR61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/jcm9010176","volume":"9","author":"TR Oh","year":"2020","unstructured":"Oh TR, Choi HS, Kim CS, Kang KP, Kwon YJ, Kim SG, Ma SK, Kim SW, Bae EH (2020) The effects of hyperuricemia on the prognosis of IgA nephropathy are more potent in females. J Clin Med 9:176","journal-title":"J Clin Med"},{"key":"5092_CR62","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11255-015-0939-7","volume":"47","author":"A Bakan","year":"2015","unstructured":"Bakan A, Oral A, Elcioglu OC, Takir M, Kostec O, Ozkok O, Basci S, Sumnu A, Ozturk S, Sipahioglu M, Turkmen A, Voroneanu L, Covic A, Kanbay M (2015) Hyperuricemia is associated with progression of IgA nephropathy. Int Urol Nephrol 47:673\u2013678","journal-title":"Int Urol Nephrol"},{"key":"5092_CR63","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000443415","volume":"41","author":"Y Caliskan","year":"2016","unstructured":"Caliskan Y, Ozluk Y, Celik D, Oztop N, Aksoy A, Ucar AS, Yazici H, Kilicaslan I, Sever MS (2016) The clinical significance of uric acid and complement activation in the progression of IgA nephropathy. Kidney Blood Press Res 41:148\u2013157","journal-title":"Kidney Blood Press Res"},{"key":"5092_CR64","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","volume":"71","author":"RJ Johnson","year":"2018","unstructured":"Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, Merriman TR, Moe OW, Mount DB, Sanchez-Lozada LG, Stahl E, Weiner DE, Chertow GM (2018) Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation. Am J Kidney Dis 71:851\u2013865","journal-title":"Am J Kidney Dis"},{"key":"5092_CR65","doi-asserted-by":"publisher","first-page":"e1002725","DOI":"10.1371\/journal.pmed.1002725","volume":"16","author":"DM Jordan","year":"2019","unstructured":"Jordan DM, Choi HK, Verbanck M, Topless R, Won H-H, Nadkarni G, Merriman TR, Do R (2019) No causal effects of serum uric levels on the risk of chronic kidney disease: a Mendelian randomization study. PLoS Med 16:e1002725","journal-title":"PLoS Med"},{"key":"5092_CR66","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/j.ajkd.2017.08.017","volume":"71","author":"A Srivastava","year":"2018","unstructured":"Srivastava A, Kaze AD, McMullan CJ, Isakova T, Waikar SS (2018) Uric acid and the risks of kidney failure and death in individuals with CKD. Am J Kidney Dis 71:362\u2013370","journal-title":"Am J Kidney Dis"},{"key":"5092_CR67","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40620-014-0154-0","volume":"28","author":"T Moriyama","year":"2015","unstructured":"Moriyama T, Itabashi M, Takei T, Kataoka H, Sato M, Shimizu A, Iwabuchi Y, Nishida M, Uchida K, Nitta K (2015) High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a. J Nephrol 28:451\u2013456","journal-title":"J Nephrol"},{"key":"5092_CR68","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1053\/j.ajkd.2015.06.015","volume":"66","author":"KE Rodenbach","year":"2015","unstructured":"Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, Warady BA, Schwartz GJ (2015) Hyperuricemia and progression of CKD in children and adolescents: the Chronic Kidney Disease in Children (CKiD) Cohort Study. Am J Kidney Dis 66:984\u2013992","journal-title":"Am J Kidney Dis"},{"key":"5092_CR69","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.clinbiochem.2013.12.025","volume":"47","author":"M Salinas","year":"2013","unstructured":"Salinas M (2013) Strategy to improve the request of uric acid in primary care: preliminary results and evaluation through process and outcome appropriateness indicators. Clin Biochem 47:467\u2013470","journal-title":"Clin Biochem"},{"key":"5092_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/labmed\/lmx075","volume":"49","author":"M Salinas","year":"2018","unstructured":"Salinas M, L\u00f3pez-Garrig\u00f3s M, Flores E, Leiva-Salinas C (2018) Serum uric acid laboratory request patterns in primary care: how panels may contribute to overutilization and treatment of asymptomatic patients. Lab Med 49:55\u201358","journal-title":"Lab Med"},{"key":"5092_CR71","first-page":"10.16966\/2380","volume":"2","author":"RJ Hogg","year":"2016","unstructured":"Hogg RJ, Bay RC (2016) High prevalence of hyperuricemia and gout in North American patients with IgA nephropathy. Int J Nephrol Kidney Failure 2:10.16966\/2380\u201310.165498.128","journal-title":"Int J Nephrol Kidney Failure"},{"key":"5092_CR72","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpeds.2012.06.008","volume":"162","author":"DG Noone","year":"2013","unstructured":"Noone DG, Marks SD (2013) Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. J Pediatr 162:128\u2013132","journal-title":"J Pediatr"},{"key":"5092_CR73","first-page":"10.16966\/2380","volume":"2","author":"T Molfino","year":"2016","unstructured":"Molfino T, Bay RC, Seeman T, Pohl M, John U, Hogg RJ (2016) Hyperuricemia and obesity in North American and European children with IgA nephropathy. Int J Nephrol Kidney Failure 2:10.16966\/2380\u201310.165498.126","journal-title":"Int J Nephrol Kidney Failure"},{"key":"5092_CR74","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1080\/15257770.2011.596496","volume":"30","author":"H Yamanaka","year":"2011","unstructured":"Yamanaka H (2011) Japanese guidelines for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids 30:1018\u20131029","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"5092_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.dsx.2020.01.007","volume":"14","author":"R Valsaraj","year":"2020","unstructured":"Valsaraj R, Singh AK, Gangopadhyay KK, Ghoshdastidar B, Goyal G, Batin M, Mukherjee D, Sengupta U, Chatterjee S, Sengupta N (2020) Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement. Diabetes Metab Syndr Clin Res Rev 14:93\u2013100","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"5092_CR76","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/14397595.2020.1784556","volume":"31","author":"R Koto","year":"2021","unstructured":"Koto R, Nakajima A, Horiuchi H, Yamanaka H (2021) Real-world treatment of gout and asymptomatic hyperuricemia: a cross-sectional study of Japanese health insurance claims data. Mod Rheumatol 31:261\u2013269","journal-title":"Mod Rheumatol"},{"key":"5092_CR77","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","volume":"72","author":"K Kimura","year":"2018","unstructured":"Kimura K, Hosoya T, Uchida S, Inaba M, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y, FEATHER Study Investigators (2018) Febuxostat therapy for patients with Stage 3 CKD and asymptomatic hyperuricemia: a randomized trial. Am J Kidney Dis 72:798\u2013810","journal-title":"Am J Kidney Dis"},{"key":"5092_CR78","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","volume":"382","author":"SV Badve","year":"2020","unstructured":"Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, Clarke P, Dalbeth N, Day RO, De Zoysa JR, Douglas B, Faull R, Harris DC, Hawley CM, GRD J, Kanellis J, Palmer SC, Perkocic V, Rangan GK, Reidlinger D, Robison L, Walker RJ, Walters G, Johnson DW, CKD-FIX Study Investigators (2020) Effects of Allopurinol on the progression of chronic kidney disease. N Engl J Med 382:2504\u20132513","journal-title":"N Engl J Med"},{"key":"5092_CR79","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1056\/NEJMe2015886","volume":"382","author":"DI Feig","year":"2020","unstructured":"Feig DI (2020) Urate lowering therapy and chronic kidney disease progression. N Engl J Med 382:2567\u20132568","journal-title":"N Engl J Med"},{"key":"5092_CR80","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/00365515909060427","volume":"11","author":"O Steenstrup","year":"1959","unstructured":"Steenstrup O (1959) The ratio between uric acid concentration in human erythrocytes and plasma. Scand J Clin Invest 11:165\u2013168","journal-title":"Scand J Clin Invest"},{"key":"5092_CR81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-4613-3822-2_4","volume-title":"Acute Renal Disorders and Renal Emergencies. Developments in Nephrology","author":"AB Gruskin","year":"1984","unstructured":"Gruskin AB, Naiman JL, Polinsky MS, Baluarte HJ, Kaiser BA, Perlnan SA, Morgenstern BZ (1984) Uric acid perturbations in the hemolytic uremic syndrome. In: Strauss J (ed) Acute Renal Disorders and Renal Emergencies. Developments in Nephrology. Springer, Boston, pp 33\u201342. https:\/\/doi.org\/10.1007\/978-1-4613-3822-2_4"},{"key":"5092_CR82","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00467-018-3979-2","volume":"34","author":"DJ Weaver Jr","year":"2019","unstructured":"Weaver DJ Jr (2019) Uric acid and progression of chronic kidney disease. Pediatr Nephrol 34:801\u2013809","journal-title":"Pediatr Nephrol"},{"key":"5092_CR83","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1681\/ASN.2020040523","volume":"31","author":"M Sellmayr","year":"2020","unstructured":"Sellmayr M, Petzsche MRH, Ma Q, Liapis H, Brink A, Lenz B, Angelotti ML, Gnemmi V, Kuppe C, Kim H, Bindels EMJ, Taiti F, Saez-Rodriguez J, Lech M, Kramann R, Romagnani P, Anders H-J, Steiger S (2020) Only hyperuricemia with crystalluria, but not asymptomatic hyperuricemia, drives progression of chronic kidney disease. J Am Soc Nephrol 31:2773\u20132792","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05092-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:24:22Z","timestamp":1699017862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05092-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["5092"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05092-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"assertion":[{"value":"3 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}